Frequencies of hprt mutant lymphocytes in marijuana-smoking mothers and their newborns

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 403, Issue 1-2, 1998, Pages 55-64

  Ammenheuser, Marinel M ^a   Berenson, Abbey B ^a   Babiak, Adriana E ^a   Singleton, Chantele R ^a   Whorton Jr , Elbert B ^b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Biomarker; Hprt mutation; Human lymphocyte; Marijuana; Prenatal health

Indexed keywords

BIOLOGICAL MARKER; CANNABIS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE;

ADULT; ARTICLE; CANNABIS ADDICTION; CHEMICAL MUTAGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENOTOXICITY; HUMAN; HUMAN CELL; LYMPHOCYTE; MOTHER CHILD RELATION; MUTAGENICITY; MUTATION RATE; NEWBORN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; SMOKING;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENES, REPORTER; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INFANT, NEWBORN; LYMPHOCYTES; MARIJUANA SMOKING; MATERNAL-FETAL EXCHANGE; MUTATION; NEOPLASMS; PREGNANCY; RISK FACTORS; SMOKING;

CANNABIS; CANNABIS SATIVA; NICOTIANA TABACUM;

EID: 0032541047     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(98)00027-X     Document Type: Article

References (46)

1. [1] L.D. Johnston, P.M. O'Malley, J.B. Bachman, National Survey Results on Drug Use from Monitoring the Future Study, 1975-1995, National Institute on Drug Abuse, Rockville, MD, NIH publication No. 96-4139, 1996, pp. 7-14.
2. [2] M.A. Stenchever, T.J. Kunysz, M.A. Allen, Chromosome breakage in users of marijuana, Am. J. Gynecol. 118 (1974) 106-113.
3. [3] E. Chiesara, R. Rizzi, Chromosome damage in heroin-marijuana and marijuana addicts, Arch. Toxicol. Suppl. 6 (1983) 128-130.
4. [4] R. Hingson, J.J. Alpert, N.L. Day, E. Dooling, H. Kayne, S. Morelock, E. Oppenheimer, B. Zuckerman, Effects of maternal drinking and marijuana use on fetal growth and development, Pediatrics 70 (1982) 539-546.
5. [5] B. Zuckerman, D. Frank, R. Hingson, A. Hortensia, S.M. Levenson, H. Kayne, S. Parker, R. Vinci, K. Aboagye, L.E. Fried, H. Cabral, R. Timperi, H. Bauchner, Effects of maternal marijuana and cocaine use on fetal growth, N. Engl. J. Med. 320 (1989) 762-768.
6. [6] M.D. Cornelius, P.M. Taylor, D. Geva, N.L. Day, Prenatal tobacco and marijuana use among adolescents: effects on offspring gestational age, growth, and morphology, Pediatrics, 1995, pp. 738-743.
7. [7] D.P. Tashkin, A.H. Coulson, V.A. Clark, M. Simmons, L.B. Bourque, S. Duann, G.H. Spivey, H. Gong, Respiratory symptoms and lung function in habitual heavy smokers of marijuana alone, smokers of marijuana and tobacco, smokers of tobacco alone, and nonsmokers, Am. Rev. Respir. Dis. 135 (1987) 209-216.
8. [8] H. Gong, S. Fligiel, D.P. Tashkin, R.G. Barbers, Tracheo-bronchial changes in habitual, heavy smokers of marijuana with and without tobacco, Am. Rev. Respir. Dis. 136 (1987) 142-149.
9. [9] T.C. Wu, M.D. Tashkin, B. Djahed, J.E. Rose, Pulmonary hazards of smoking marijuana as compared with tobacco, N. Engl. J. Med. 318 (1988) 347-351.
10. [10] F.M. Taylor III, Marijuana is a potential respiratory tract carcinogen: a retrospective analysis of a community hospital population, South. Med. J. 81 (1988) 1213-1216.
11. [11] G.A. Caplan, B.A. Brigham, Marijuana smoking and carcinoma of the tongue, Cancer 66 (1990) 1005-1006.
12. [12] P.J. Donald, Marijuana and upper aerodigestive tract malignancy in young patients, in: G.G. Nahas, C. Latour (Eds.), First International Colloquium on Illicit Drugs, Advances in the Biosciences, Pergamon, Oxford, 1991, pp. 39-54.
13. [13] S. Zimmerman, A.M. Zimmerman, Genetic effects of marijuana, Int. J. Addict. 25 (1A) (1990) 19-23.
14. [14] G. Nahas, C. Latour, The human toxicity of marijuana, Med. J. Aust. 156 (1991) 49-57.
15. [15] P.A. Fried, Prenatal exposure to tobacco and marijuana: effects during pregnancy, infancy, and early childhood, Clin. Obstet. Gynecol. 36 (1993) 319-337.
16. [16] NRC, Committee on biological markers of the National Research Council, biological markers in environmental health research, Environ. Health Perspect. 74 (1991) 3-9.
17. [17] P.A. Schulte, F.P. Perrera (Eds.), Molecular Epidemiology, Academic Press, New York, 1993, pp. 1-558.
18. [18] J.B. Ward Jr., R.E. Henderson, Identification of needs in biomarker research, Environ. Health. Perspect. 104 (Suppl. 5) (1996) 895-900.
19. [19] J.B. Ward Jr., M.M. Ammenheuser, W.E. Bechtold, E.B. Whorton Jr., M.S. Legator, Hprt mutant lymphocyte frequencies in workers at a 1,3-butadiene production plant, Environ. Health Perspect. 102 (1994) 79-85.
20. [20] J.B. Ward Jr., M.M. Ammenheuser, E.B. Whorton Jr., W.E. Bechtold, K.T. Kelsey, M.S. Legator, Biological monitoring for mutagenic effects of occupational exposure to butadiene, Toxicology 110 (1996) 1-7.
21. [21] M.M. Ammenheuser, J.B. Ward Jr., E.B. Whorton Jr., J.M. Killian, M.S. Legator, Elevated frequencies of 6-thioguaine resistant lymphocytes in multiple sclerosis patients treated with cyclophamide: a prospective study, Mutat. Res. 204 (1988) 509-520.
22. [22] M.M. Ammenheuser, W.W. Au, E.B. Whorton Jr., J.A. Belli, J.B. Ward Jr., Comparison of hprt variant frequencies and chromosome aberration frequencies in lymphocytes from radiotherapy and chemotherapy patients: a prospective study, Environ. Mol. Mutagen. 18 (1991) 126-135.
23. [23] M.M. Ammenheuser, A.B. Berenson, N.J. Stiglich, E.B. Whorton Jr., J.B. Ward Jr., Elevated frequencies of hprt mutant lymphocytes in cigarette-smoking mothers and their newborns, Mutat. Res. 304 (1994) 285-294.
24. [24] M.M. Ammenheuser, D.A. Hastings, E.B. Whorton Jr., J.B. Ward Jr., Frequencies of hprt mutant lymphocytes in smokers, non-smokers, and former smokers, Environ. Mol. Mutagen. 30 (1997) 131-138.
25. [25] R.J. Albertini, Somatic gene mutations in vivo as indicated by the 6-thioguanine-resislant T-lymphocytes in human blood, Mutat. Res. 150 (1985) 411-422.
26. [26] R.N. Forther, E.S. Lee, Introduction to Biostatistics, Academic Press, San Diego, CA, 1995, pp. 283-290.
27. [27] H. Van Vunakis, H.B. Gjika, J.J. Langone, Radioimmunoassay for nicotine and cotinine, in: I.K. O'Neil, K.D. Brunnemann, B. Hoffman (Eds.), Environmental Carcinogens: Methods of Analysis and Exposure, Vol. 9, International Agency for Research on Cancer, Lyon, 1987, pp. 317-330.
28. [28] N.L. Benowitz, F. Kuyt, R. Jacob, R.T. Jones, A. Osman, Cotinine disposition and effects, Clin. Pharmacol. Ther. 34 (1983) 604-611.
29. [29] R.L. Hawks, Analytical methodology, in: R.L. Hawks, C.N. Chiang (Eds.), Urine testing for Drugs of Abuse, NIDA Research Monograph No. 73, National Institute on Drug Abuse, Rockville, MD, DHHS Publication No: (ADM) 87-1481, 1986, pp. 30-42.
30. [30] G.M. Ellis Jr., M.A. Mann, B.A. Judson, N.T. Schramm, A. Tashchian, Excretion patterns of cannabinoid metabolites after last use in a group of chronic users, Clin. Pharmacol. Ther. 38 (1985) 572-578.
31. [31] R.J. Albertini, J.A. Nicklas, J.P. O'Neill, S.H. Robison, In vivo somatic mutations in humans: measurement and analysis, Annu. Rev. Genet. 24 (1990) 305-326.
32. [32] M.L. Lee, M. Novotney, K.D. Bartle, Gas chromatography/mass spectrometric and nuclear magnetic resonance spectrometric studies of carcinogenic polynuclear aromatic hydrocarbons in tobacco and marijuana smoke condensates, Anal. Chem. 48 (1976) 405-416.
33. [33] D.M. DeMarini, Genotoxicology of tobacco smoke and tobacco smoke condensate, Mutat. Res. 114 (1983) 59-89.
34. [34] J.B. Adams, K. O'Mara-Adams, D. Hoffman, Toxic and carcinogenic agents in undiluted mainstream smoke and sidestream smoke of different types of cigarettes, Carcinogenesis 8 (1987) 729-731.
35. [35] D.G. Gilmore, A.D. Blood, K.P. Lele, E.S. Robbins, C. Maximillian, Chromosomal aberrations in users of psychoactive drugs, Arch. Gen. Psychiatry 24 (1971) 268-272.
36. [36] J. Herha, G. Obe, Chromosomal damage in chronical users of cannabis: in vivo investigation with two-day lymphocyte cultures, Pharmakopsychiatrie 7 (1974) 328-337.
37. [37] D. Dorrance, O. Janiger, R.L. Teplitz, In vivo effects of illicit hallucinogens on human lymphocyte chromosomes, J. Am. Med. Assoc. 212 (1970) 1488-1491.
38. [38] S.S. Matsuyama, F.S. Yen, L.F. Jarvik, R.S. Sparkes, T.K. Fu, H. Fisher, N. Reccius, I.M. Frank, Marijuana exposure in vivo and human lymphocyte chromosomes, Mutat. Res. 48 (1977) 255-266.
39. [39] K. Steenland, A. Carrano, J. Ratcliffe, D. Clapp, L. Ashworth, T. Meinhardt, A cytogenetic study of papaya workers exposed to ethylene dibromide, Mutat. Res. 170 (1986) 151-160.
40. [40] F.W. Busch, D.A. Seid, E.T. Wei, Mutagenic activity of marijuana smoke condensates, Cancer Lett. 6 (1979) 319-324.
41. [41] C.M. Sparacino, P.A. Hyldbrug, T.J. Hughes, Chemical and biological analysis of marijuana smoke condensate, in: C.N. Chiang, R.L. Hawks (Eds.), Research Findings on Smoking of Abused Substances, NIDA Research Monograph No. 99, National Institute on Drug Abuse, DHHS, Rockville, MD, (Publication No. 91-141119) 1990, pp. 121-140.
42. [42] M.M. Ammennheuser, A.B. Berenson, C.S. Singleton, D.A. Hastings, E.B. Whorton Jr., J.B. Ward Jr., Frequencies of hprt mutant lymphocytes in marijuana smokers and multidrug users, Mutat. Res. 379 (S1) (1997) S158, Abstr.
43. [43] R.C. Peterson, Importance of inhalation patterns in determining effects of marijuana use, Lancet 1 (1979) 727-728.
44. [44] L.L. Robison, J.D. Buckley, A.E. Daigle, R. Wells, D. Benjamin, D.C. Arthur, G.D. Hammond, Maternal drug use and risk of childhood nonlymphoblastic leukemia among offspring. An epidemiologic investigation implicating marijuana, Cancer 63 (1989) 1904-1910.
45. [45] R.A. Weinberg, Oncogenes, antioncogenes and the molecular basis of multistep carcinogenesis, Cancer Res. 49 (1989) 3713-3721.
46. [46] L. Hagmar, A. Brogger, I.-L. Hansteen, S. Heim, B. Hogstedt, L. Knudsen, B. Lambert, K. Linnainmaa, F. Mitelman, I. Nordenson, C. Reuterwall, S. Salomaa, S. Skerfving, M. Sorsa, Cancer risks in humans predicted by increasing levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage, Cancer Res. 54 (1994) 2919-2922.